Xueping Lin
Impact in
-
- Nanoparticles: synthesis and applications
- Advanced Nanomaterials in Catalysis
-
- Cancer, Stress, Anesthesia, and Immune Response
Papers in
- Surgery 5
- Co-authors
- Haoran Zhang (1 shared paper)Daohua Sun (1 shared paper)Ning He (1 shared paper)Yinghua Lu (1 shared paper)Shuzhen Zheng (1 shared paper)Qingbiao Li (1 shared paper)Xu Deng (1 shared paper)Zhongwei Lv (1 shared paper)
- Journals
- Cellular and Molecular Biology (1 paper)PeerJ (1 paper)The FASEB Journal (1 paper)PLoS ONE (1 paper)Journal of Ovarian Research (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xueping Lin
22 papers receiving 361 citations
Peers
Comparison fields: 5 of 69
- Materials Chemistry 140
- Psychiatry and Mental health 35
- Cancer Research 35
- Biomedical Engineering 113
- Nephrology 16
Countries citing papers authored by Xueping Lin
This map shows the geographic impact of Xueping Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueping Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueping Lin more than expected).
Fields of papers citing papers by Xueping Lin
This network shows the impact of papers produced by Xueping Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueping Lin. The network helps show where Xueping Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Xueping Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 160 | |
| 2 | 2013 | 44 | |
| 3 | 2018 | 26 | |
| 4 | 2016 | 22 | |
| 5 | 2017 | 20 | |
| 6 | 2018 | 17 | |
| 7 | 2015 | 16 | |
| 8 | 2019 | 12 | |
| 9 | 2020 | 11 | |
| 10 | 2018 | 10 | |
| 11 | 2011 | 9 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 6 | |
| 14 | 2017 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2018 | 3 | |
| 17 | 2022 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2023 | 1 | |
| 20 | 2021 | 1 |
About Xueping Lin
Xueping Lin is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Nephrology and Organic Chemistry, having authored 22 papers that have together received 378 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Renal Diseases and Glomerulopathies (2 papers), Diabetes Management and Research (1 paper), Nitric Oxide and Endothelin Effects (1 paper), Cancer Genomics and Diagnostics (1 paper), Gout, Hyperuricemia, Uric Acid (1 paper) and Nanoparticles: synthesis and applications (1 paper). The work is most often cited by research in Materials Chemistry (140 citations), Psychiatry and Mental health (35 citations), Cancer Research (35 citations), Biomedical Engineering (113 citations) and Nephrology (16 citations). Xueping Lin has collaborated with scholars based in China and United States. Frequent co-authors include Haoran Zhang, Daohua Sun, Ning He, Yinghua Lu, Shuzhen Zheng, Qingbiao Li, Xu Deng, Zhongwei Lv, Jian Huang and Kai Luo. Their work appears in journals such as Cellular and Molecular Biology, PeerJ, The FASEB Journal, PLoS ONE and Journal of Ovarian Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.